Compound class:
Synthetic organic
Comment: LY3509754 is an orally bioavailable, small molecule inhibitor of the proinflammatory cytokine IL-17A [1]. It was intended as an alternative to anti-IL-17A monoclonals for the treatment of psoriasis.
|
|
Classification | |
Compound class | Synthetic organic |
Database Links | |
CAS Registry No. | 2452464-73-0 (source: PubChem) |
GtoPdb PubChem SID | 491299946 |
PubChem CID | 154642729 |
Search Google for chemical match using the InChIKey | MVWVCLAORBNXSD-UWVAXJGDSA-N |
Search Google for chemicals with the same backbone | MVWVCLAORBNXSD |
UniChem Compound Search for chemical match using the InChIKey | MVWVCLAORBNXSD-UWVAXJGDSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | MVWVCLAORBNXSD-UWVAXJGDSA-N |